Continuing Pharmacy Education / CE Master List / Law: Seniors Self-Diagnosing and Treating: A Brave (and scary) New World-RECORDED WEBINAR
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

Law: Seniors Self-Diagnosing and Treating: A Brave (and scary) New World-RECORDED WEBINAR

About this Course

This course is a recorded (home study version) of the 2024 CE Finale Encore Webinars.

 

Learning Objectives

Upon completion of this application based CE Activity, a pharmacist will be able to:

Describe the reasons seniors are increasingly diagnosing and treating themselves with therapies
Describe the legal and regulatory pathways that provide seniors access to therapies outside the drug supply chain
Describe the ways that pharmacists can recommend dietary supplements that are free of adulterants and contaminants
Describe the risks associated with self-treatment with dietary supplements, “peptides”, and counterfeit drug

Release and Expiration Dates

Released:  December 13, 2024
Expires:  December 13, 2027

Course Fee

$17 Pharmacist

ACPE UAN

0009-0000-24-044-H03-P

Session Code

24RW44-BVF28

Accreditation Hours

1.0 hours of CE

Additional Information

 

How to Complete Evaluation:  When you are ready to submit quiz answers, go to the BLUE take test/evaluation button.  Don't forget to use the session code above, or that was sent to you in your confirmation email NOT the one on the presentation!

Accreditation Statement

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs)  for completing the activity ACPE UAN 0009-0000-24-044-H03-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

C. Michael White, PharmD, FCCP, FCP
BOT Distinguished Professor and Chair of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • Dr. White has no financial relationships with ineligible companies.

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Content

Handouts

Download

Post Test

    Pharmacist Post Test

     

    1. Don is a 72-year-old who is looking online for alternatives to self-manage his pain. His prescriber told him he would not write any other prescriptions for oxycodone with APAP. He is looking at kratom and for Canadian Pharmacies that don’t require a prescription. Which of the following is the motivator for Don to transcend the normal medication supply chain?
    1. Cost of prescription options
    2. Circumvent prescriber gatekeeping restrictions
    3. Embarrassment over his health issue

     

    1. You are a pharmacist at a community pharmacy and a patient asks you which supplements to buy. What is a validated way to assure the dietary supplement you recommend does not have excessive microbial or heavy metal contamination and has the ingredients in the tablets/capsules advertised on the label?
    1. USP certification
    2. Better Homes and Gardens Certification
    3. The most expensive one

     

    1. Sylvia is a 68-year-old woman who weighs 120 pounds but wants to weigh 108 pounds like she did when she was 40 years old. Which of the following is a good counseling point if she reveals she is using a “peptide” GLP-1 product?
    1. Her obesity is a disorder that requires a GLP-1 product, so the benefits outweigh the risks
    2. These products are known to contain lead and arsenic in too high a level
    3. The labeled dose could vary, and she could overdose or underdose as a result

     

    1. Don from question 1 finds a “pharmacy” willing to sell him oxycodone with APAP for $7 a pill without a prescription. The site says it is a best seller in Canada. What is the main risk of Don getting his opioids from the unlicensed online site?
    1. Fentanyl adulteration and dose variability could lead to respiratory depression
    2. It is more expensive than the brand name prescription version he now takes
    3. The company offers no certificate of analysis or money back guarantee

     

    1. A company says its melatonin supplement can “support a restful sleep” and that “this product is not intended to diagnose, evaluate, or treat any disease.” What would the FDA call this?
    1. A legitimate health claim
    2. A legitimate quasi health claim
    3. A legitimate semi-health claim

     

    1. A woman calls a company that sells “Energy Macha” to complain that her newborn has an extra arm with seven fingers. How long does the company have to alert the FDA about this serious potential adverse event?
    1. 1-day
    2. 5-days
    3. 15-days

     

    1. Which of the following common adulterants is matched with the type of dietary supplement it is associated with?
    1. Weight Loss – human growth hormone
    2. Muscle Building – sildenafil
    3. Sexual Enhancement – tadalafil

     

    1. What is the name of the law that controls FDA authority over dietary supplements?
    1. DSHEA 1994
    2. OBRA 1990
    3. FDCA 1927

     

    VIDEO